Master of Pharmacy (Pharmaceutics)tmu.ac.in/.../6/2016/05/syllabusmpharmapharmaceutics1213.pdfM....
Transcript of Master of Pharmacy (Pharmaceutics)tmu.ac.in/.../6/2016/05/syllabusmpharmapharmaceutics1213.pdfM....
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 1 of 20
Study & Evaluation Scheme
of
Master of Pharmacy
(Pharmaceutics) [Applicable w.e.f. Academic Session 2011-12 till revised]
[With amendments in Credit scheme, MPU 251, 351 & 451 vide approval dated 17th
Nov 2012]
TEERTHANKER MAHAVEER UNIVERSITY N.H.-24, Delhi Road, Moradabad, Uttar Pradesh-244001
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 2 of 20
Website: www.tmu.ac.in
Study & Evaluation Scheme
of
MASTER OF PHARMACY
SUMMARY
Programme : M. Pharm. (Pharmaceutics)
Duration : Two years full time
Medium : English
Minimum Required Attendance : 75 %
Credit
Maximum Credits : 71 Minimum credits required for degree : 66
Assessment
:
Internal External Total
30 70 100
Internal Evaluation (Theory Papers) :
Clas
s
Test
I
Clas
s
Test
II
Clas
s
Test
III
Continuou
s
Evaluatio
n
Semin
ar
Total
10 10 10 5 5 30
Duration of Examination :
Theory Practical
External Internal External Internal
3 hrs. 1.5 hrs. 4 hrs. 4 hrs.
To qualify the course a student is required to secure a minimum of 40% marks in aggregate in the end
semester examination and teachers continuous evaluation (i.e. both internal and external). A candidate who
secures less than 40% of marks in a course shall be deemed to have failed in that course. The student should
have overall 50% marks in a semester to clear the semester. In case a student has more than 40% in each
course but less than 50% overall in a semester he/she shall re-appear in one or two course(s) to improve the
percentage. There will be three Class Tests in a semester and an average of the marks obtained in best two
tests will be computed (cumulatively) for the final result.
The class tests would comprise of five questions. Student shall have to answer three questions out of which
one question will be compulsory. Each question would be of five marks.
Question Paper Structure:
1. The question paper shall consist of eight questions. Out of which first question shall be of short
answer type (not exceeding 50 words) and will be compulsory. Question No. 1 shall contain 8 parts
representing all units of the syllabus and students shall have to answer any five (weightage 4 marks
each).
2. Out of the remaining seven questions, a student shall be required to attempt any five questions.
There will be minimum one and maximum two questions from each unit of the syllabus. The
weightage of Question No. 2 to 8 shall be 10 marks each.
TTEEEERRTTHHAANNKKEERR MMAAHHAAVVEEEERR UUNNIIVVEERRSSIITTYY ((EEssttaabblliisshheedd uunnddeerr GGoovvtt.. ooff UU.. PP.. AAcctt NNoo.. 3300,, 22000088))
DDeellhhii RRooaadd,, BBaaggaarrppuurr,, MMoorraaddaabbaadd ((UU..PP))
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 3 of 20
Study & Evaluation Scheme
Programme: M. Pharm. Semester I
S.N.
Course
Code
Subject Periods
C
Evaluation Scheme
L T P Internal External Total
1 MPA101 Modern Analytical Techniques 4 2 - 5 30 70 100
2 MPU101 Pharmaceutical Biostatics and
Computer Application
4 2 - 5 30 70 100
3 MPU102 Product Development 4 2 - 5 30 70 100
4 MPA151 Modern Analytical Techniques
(MAT) Lab
- - 8 4 30 70 100
Semester II
S.N.
Course
Code
Subject Periods Credits Evaluation Scheme
L T P Internal External Total
1 MPU201 Pharmaceutical Production
Management
4 2 - 5 30 70 100
2 MPU202 Recent Advances in Drug
Delivery System
4 2 - 5 30 70 100
3 MPU203 Bio-pharmaceutics &
Pharmacokinetics
4 2 - 5 30 70 100
4 MPU251 Research Project Synopsis - 2 - 1 100 0 100
5 MPU252 Recent Advances in Drug
Delivery System Lab
- - 8 4 30 70 100
6 MPU253 Bio-pharmaceutics &
Pharmacokinetics Lab
- - 8 4 30 70 100
Total 12 8 16 24 250 350 600
Semester III
S.N.
Course
Code
Subject Periods Credits Evaluation Scheme
L T P Internal External Total
1 MPU351 Research Project Phase -I - - 48 6 100 0 100
Total - - 48 6 100 0 100
Semester IV
S.N.
Course
Code
Subject Periods Credits Evaluation Scheme
L T P Internal External Total
1 MPU451 Research Project Phase -II
(Thesis compilation and
Viva-Voce)
- - 48 18 25 75 100
Total - - 48 18 25 75 100
Research Project shall be carried out in different stages. It will commence with submission and approval of
synopsis in second semester. The experimental work shall be carried out in two phases i.e. in III & IV
semesters.
Note: L – Lecture T- Tutorial P- Practical C- Credits
1L = 1Hr 1T= 1 Hr 1P=1 Hr 1C =1Hr of Theory paper
= 2Hrs of Practical
5 MPU152 Product Development Lab - - 8 4 30 70 100
Total 12 6 16 23 150 350 500
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 4 of 20
M. Pharm. – Semester I
MODERN ANALYTICAL TECHNIQUE
Course Code: MPA101 L-4, T-2, P-0, C-5
Objective: The basic objective of this course is to get familiar with Principle, theory &
instrumentation of sophisticated pharmaceutical analysis instruments and the interpretation of their spectra.
Unit - 1
Principle, theory & instrumentation of UV-Visible spectroscopy, it’s utility in structural qualitative
and quantitative analysis of drug molecules, Woodward Fischer rules and use of Shiff’s reagents for
elucidation of structure. (8 Hours)
Unit – 2
Infrared spectroscopy, I.R radiation and its interaction with organic molecules, vibrational mode of
bonds, instrumentation and application, effect of hydrogen bonding and conjugation on absorption
bands, interpretation of IR Spectra, FTIR and ATR. (8 Hours)
Unit – 3
Nuclear magnetic resonance spectroscopy: chemical shift concept, isotopic nuclei, reference
standards and solvents. 1H NMR spectra, coupling constants, interpretation of spectra, decoupling-double resonance and shift reagent methods.
Principles of FT-NMR with reference to 13C NMR, free induction decay. Spin-spin and spin-lattice
relaxation phenomenon. Nuclear overhauser enhanced 13C NMR spectra, their interpretation and
application. (8 Hours)
Unit – 4
Mass spectrometry: Basic principles and brief outline of instrumentation. Ion formation, molecular
ion, metastable ion, fragmentation process in relation to molecular structure and functional groups.
Relative abundance of isotopes, chemical ionization, GC-MS and LC/MS. Interpretation of spectra
of simple molecules. (8 Hours)
Unit – 5
Chromatographic techniques: Principles of separation and application of Column, Paper, Thin layer and Gas chromatography, HPLC, HPTLC, Electrophoresis. Instrumentation of HPLC, Reverse phase
columns. Pharmaceutical evaluation of drug in biological fluids- bioassays. Radioimmunoassay.
(8 Hours)
Recommended Books
1. Willard, H.H., Merrit, L.L., Dean, J.A., Settle, P.A., Instrumental Methods of Analysis, Van
Nostrand. 2. Skoog, D.A., Heller, F.J., Nieman, T.A., Principles of Instrumental Analysis, WB Saunders.
3. Haswell, S.J., ed. Atomic Absorption Spectroscopy, Elsevier. 4. Ardrey, R.E., Pharmaceutical Mass Spectra, Pharmaceutical Press, London.
5. Sethi, P.D., Quantitative Analysis of Pharmaceutical Formulations, CBS Publishers, New Delhi. 6. Kalsi, P.S., Spectroscopy of Organic Compounds, New Age Publishers, New Delhi.
7. Gross J.H., Mass Spectrometry, Springer Berlin, Heidelberg. 8. Haffmann D. H., Advances in Chromatography, Marcel Dekker.
9. Robert D. Braun, Introduction to Instrumental Analysis, McGraw-Hill.
10. Wilfried, M.A. Niessen- Liquid Chromatography-Mass Spectrometry, Marcel Dekker.
*Latest editions of all the suggested books are recommended.
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 5 of 20
Semester I
PHARMACEUTICAL BIOSTATICS AND COMPUTER APPLICATIONS
Course Code: MPU101 L-4, T-2, P-0, C-5
Objective: The basic objective of this course is to get familiar with pharmaceutical biostatics and
computer applications.
Unit - 1 Methods of collection of data, classifications and graphical representation of data. Binomial and
normal probability distribution. Polygon, histogram, measure of central tendency. Significance of
statistical methods, probability, degree of freedom, measures of variation - Standard deviation,
Standard error. (8 Hours)
Unit - 2
Sampling, sample size and power. Statistical inference and hypothesis. Tests for statistical
significance: student t-test, Chi-square test, confidence level, Null hypothesis. (8 Hours)
Unit - 3
Linear regression and correlation. Analysis of Variance (one way and two way). Factorial designs
(including fraction factorial design). Theory of probability, Permutation and Combination, Ratios,
Percentage and Proportion. Two way ANOVA and Multiple comparison procedures. (8 Hours)
Unit - 4
Non-parametric tests, Experimental design in clinical trials, Statistical quality control, Validation, Optimization techniques and Screening design. Correlation and regression, least square method,
significance of coefficient of correlation, nonlinear regression. (8 Hours)
Unit - 5 Bioassays-calculations of doses response relationships, LD50, ED50. Applications of software for
statistical calculation viz. SPSS, foxtron. (8 Hours)
Recommended Books
1. Bolton, Pharmaceuticals Statistics- Practical & Clinical Applications, Marcel & Dekker, New
York. 2. Fisher, R.A., Statistical Methods for Research Works, Oliver & Boyd, Edinburgh.
3. Chow, Statistical Design and Analysis of Stability Studies, Marcel Dekker, New York.
4. Buncher, Statistics in the Pharmaceutical Industry, Marcel Dekker, New York.
5. Finney, D.J., Statistical Methods in Biological Assays, Hafner, New York.
6. Montgomery, D.C., Introduction to Statistical Quality Control, Willy.
7. Lipschutz, Introduction to Probability and Statistics, McGraw-Hill.
8. Li wan Po, Statistics for Pharmacist, Wiley-Blackwell.
* Latest editions of all the suggested books are recommended.
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 6 of 20
Semester I
PRODUCT DEVELOPMENT Course Code: MPU102 L-4, T-2, P-0, C-5
Objective: The basic objective of this course is to get familiar with product development.
Unit-1
PREFORMULATION STUDIES
Timings and goals of Preformulation. pre-formulation methodology, solid stat properties, partition coefficient, solubility, dissolution, crystal from the stability, compatibility tests, dissolution of drug
substances and dosage forms, Pediatric & geriatric aspects of formulation. (8 Hours)
Unit -2
PHARMACEUTICAL PROCESS VALIDATION
Regulatory basis, validation of sterile products, solid dosage forms, process. Drug additive
interaction. (8 Hours)
Unit-3
STABILITY
Theoretical considerations, Degradative pathways, Stability indicating assays, Influence of
packaging components on dosage form stability, Stabilization of Pharmaceutical formulations (solid,
liquid and semi solid formulations). (8 Hours)
Unit-4
Evaluation of Pharmaceutical formulations in vitro and in vivo studies and their correlation. Levels and types of IV-IVC. (8 Hours)
Unit -5
POLYMERS Types, Pharmaceutical Application, Molecular Weight Determination, Conformation of dissolved
linear macromolecules, Polymer solutions, Polymer in solid state, Fabrication.
PACKAGING DEVELOPMENT- Packaging materials, Types, Labeling, Preformulation screening
of packaging components. (8 Hours)
Recommended Books 1. Bannker G.S., & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York.
2. Liberman H.A. et al, Pharmaceutical Dosage Forms-Tablets, Marcel Dekker, New York.
3. Lachman L, Lieberman H.A. & Kanig J.L. The Theory & Practice of Industrial Pharmacy.
Varghese Publishing Home.
4. Aulton M.E., Pharmaceutics-The Science of Dosage form Design, Churchill Livingstone.
5. Liberman H.A. et al, Pharmaceutical Dosage Forms-Parenterals, Marcel Dekker, New York.
6. Carstensen J.T., Drug Stability-Principles & Practice, Marcel Dekker, New York.
7. Malmsten M., Surfactants and Polymers in Drug Delivery, Marcel Dekker, New York. 8. Ansel H.A. - Pharmaceutical Dosage Forms, Lippincott Williams & Wilkins.
9. Sarfaraz K. Niazi, Handbook of Preformulations: Chemical, Biological and Botanical Drugs,
CRC Press.
*Latest editions of all the suggested books are recommended
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 7 of 20
Semester I MODERN ANALYTICAL TECHNIQUE (MAT) LAB
Course Code: MPA151 L-0, T-0, P-8, C-4
Objective: The basic objective of this course is to get familiar with different analytical instruments.
Based on the Course Code: MPA101
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 8 of 20
Semester I
PRODUCT DEVELOPMENT LAB
Course Code: MPU152 L-0, T-0, P-8, C-4
Objective: The basic objective of this course is to get familiar with product development practicals.
Based on Course Code MPU103
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 9 of 20
Semester II
PHARMACEUTICAL PRODUCTION MANAGEMENT
Course Code: MPU201 L-4, T-2, P-0, C-5
Objective: The basic objective of this course is to get familiar with pharmaceutical production
management.
Unit-1 Status of Pharmaceutical industry with special reference to post GATT scenario.
Project planning and implementation.
Transfer of Technology. (8 Hours)
Unit-2
Master formula generation and SOP.
Pilot plant scale up techniques. (8 Hours)
Unit-3
Factory layout, Material Management: (8 Hours)
Unit-4 Process optimization and automation in pharmaceutical manufacturing. (8 Hours)
Unit-5
Inventory control. Different Systems of inventory control. Import and Export regulations laws and
methods to obtain I & E licenses, I and E regulations USA, EU and Japanese perspectives. (8 Hours)
Recommended Books
1. Banker G.S., & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York.
2. Remington, The Science & Practice of Pharmacy, Lippincott. William & Wilkins.
3. Lachman L, Lieberman H.A. & Kanig J.L., The Theory & Practice of Industrial Pharmacy,
Varghese Publishing Home.
4. Aulton M.E., Pharmaceutics – The Science of Dosage form Design, Churcill Livingstone.
5. Levin M.A., Pharmaceutical Process Scale up, Marcel Dekker, New York.
6. Dutta A.K., Material Management, Prentice Hall India.
7. Chary S.N., Production and Operative Management, Tata-Mcgraw Hill, India.
8. Kennedy T., Pharmaceutical Project Management, Marcel Dekker, New York.
* Latest editions of all the suggested books are recommended
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 10 of 20
Semester II
RECENT ADVANCES IN DRUG DELIVERY SYSTEM
Course Code: MPU202 L-4, T-2, P-0, C-5
Objective: The basic objective of this course is to get familiar with novel techniques and advances in
drug delivery system.
Unit-1
Formulation considerations with special emphasis on release patterns.
Sustained and Controlled release- oral, dental, nasal, ocular & parenteral systems. (8 Hours)
Unit-2
Fast Release- Introduction, formulation & evaluation. (8 Hours)
Unit-3 Transdermal Drugs Delivery System- Factors influencing transdermal delivery, formulation &
evaluation including Iontophoresis and Ionophoresis. (8 Hours)
Unit-4 Target Oriented Drug Delivery Systems- prodrugs, Liposome, Niosome, nanoparticles Microspheres and
microparticles. Lipoproteins Activated Carbons, Cellular Carriers, Antibodies, DNA, And Low
Molecular Weight Proteins.
Hormones, Dextran & Polysaccharides, Synthetic Polymers, Nanoparticles, Microparticles fabrication
techniques (Latest Advances). (8 Hours)
Unit-5
Nutraceuticals- introduction & scope. (8 Hours)
Recommended Books 1. Chien Y.W., Novel Drug Delivery Systems-Fundamentals, Developmental Concepts. Biomedical
Assessment, Marcel Dekker, New York.
2. Chien Y.W., ed., Transdermal Controlled Systemic Medications, Marcel Dekker, New York.
3. Schreyer, H., Drug Targeting Technology Physical, Chemical & Biological Methods, Marcel
Dekker, New York.
4. Banker G.S. & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York.
5. Gennaro A.R., Remington, The Science & Practice of Pharmacy, Lippincott. Williams & Wilkins.
6. Lachman L., Lieberman B.A & Kanig I.L., The Theory & Practice of Industrial Pharmacy,
Varghese Publishing Home.
7. Aulton M.E., Pharmaceutics-The Science of Dosage form Design, Churchill Livingstone.
8. Potts R.O. & Guy R.H., Mechanism of Trans dermal Drug Delivery, Marcel Dekker, New York.
* Latest editions of all the suggested books are recommended.
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 11 of 20
Semester II
BIO-PHARMACEUTICS & PHARMACOKINETICS
Course Code: MPU203 L- 4, T-2, P-0, C-5
Objective: The basic objective of this course is to get familiar with bio-pharmaceutics &
pharmacokinetics.
Unit-1
Drug Absorption Distribution & Disposition. (8 Hours)
Unit-2 Pharmacokinetics. Open one compartment, two compartment & three compartment models & their
limitations.
Non-compartmental pharmacokinetics. Graphical methods of calculating pharmacokinetic parameters.
(8 Hours)
Unit-3
Factors influencing bio-availability, evaluation of bioavailability, bio-equivalence with reference to
BCS. (8 Hours)
Unit-4
Dosage Regimens, Repetitive dosing and dose adjustments in renal and hepatic failure, individualization
of dosage regimen. (8 Hours)
Unit-5
Pharmacokinetic applications in Clinical practice. Principles of clinical trial. (8 Hours)
Recommended Books
1. Notari, R.E., Biopharmaceutics and Pharmacokinetics – An introduction, Marcel Dekker Inc. N.Y.
2. Rowland M., and Tozer T.N., Clinical Pharmacokinetics, Lea and Febriger, N.Y.
3. Wagner J.G., Fundamentals of Clinical Pharmacokinetics, Drugs Intelligence Publishers, Hamilton.
4. Wagner J.G., Pharmacokinetics for the Pharmaceutical Scientist, Technomic Publishing A.G. Basel,
Switzerland.
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 12 of 20
Semester II
RESEARCH PROJECT SYNOPSIS [Amended vide approval dated 17
th Nov 2012]
Course Code: MPU251 L-0, T-2, P-0, C-1 Objective: The basic objective of this course is to get familiar with the method, instrumentation and the
technology of the topic that is selected for the dissertation.
Guidelines:
1. The course will comprise of preparation of synopsis for the proposed research work to be done
during third and fourth semester courses.
2. The allotted supervisor will provide guidelines and determine the topic of the research work
based on thorough literature reviews.
3. The final presentation will be evaluated by the College CRC and the supervisor(s) based on the
quality of the work and its relevance in the pharmaceutical field.
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 13 of 20
EVALUATION SHEET
Name of Candidate:
Roll No:
Class and Section:
Please evaluate out of marks as indicated.
Subject Code:
Subject: RESEARCH PROJECT SYNOPSIS
Name of Candidate: Roll No:
Please evaluate out of marks as indicated.
S.N
o
Details Examiner I Examiner II Examiner III Average
Marks (25) Marks (25) Marks (25) Marks
(25)
Maximum marks in each column ( 5 marks x5) (5 marks x5) (5 marks x5)
1 OBJECTIVE IDENTIFIED & UNDERSTOOD
2
LITERATURE REVIEW / BACKGROUND
WORK
(Coverage, Organization, Critical review)
3 DISCUSSION/CONCLUSIONS
(Clarity, Exhaustiveness)
4 SLIDES/PRESENTATION SUBMITTED
(Readable, Adequate)
5
FREQUENCY OF INTERACTION ( Timely
submission, Interest shown, Depth,
Attitude)
Total
Signature with date
Signature and date of the Director/
Principal
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 14 of 20
Semester II
RECENT ADVANCES IN DRUG DELIVERY SYSTEM LAB
Course Code MPU252 L-0, T-0, P-8, C-4
Objective: The basic objective of this course is to get familiar with practicals related novel techniques
and advances in drug delivery system.
Based on the Course Code: MPU202
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 15 of 20
Semester II
BIO-PHARMACEUTICS & PHARMACOKINETICS LAB
Course Code: MPU253 L- 0, T-0, P-8, C-4
Objective: The basic objective of this course is to get familiar with pharmacokinetic practicals.
Based on the Course Code: MPU203
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 16 of 20
Semester III
RESEARCH PROJECT (PHASE-I) [Amended vide approval dated 17
th Nov 2012]
Course Code: MPU351 L- 0, T-0, P-48, C-06
Objective: The basic objective of this course is to represent the findings of the project that has been
done in the dissertation.
Guidelines: 1. The course will comprise of the confirmation of the proposed research work based on the initial
experimentation to confirm the feasibility of the work.
2. The allotted supervisor(s) will provide guidelines with exploration of the line of action with
recent trends of research in the related field and confirm global acceptability with regards to industry
and academic problems.
3. The continuous literature survey and modification of experimental pathway will be taken in to
practice with regular monitoring.
4. The candidate’s performance will be evaluated as follows:
There will be at least two seminars to be presented before the CRC during the semester consisting of the
progress of the research work. An end semester seminar will be held in the month of December/ January
under .The assessment will be 100 % internal the college committee will include at least following 3
members:-
• Seminar in-charge
• Supervisor
• Head of the department/ faculty member from the specialized field other than the supervisor
nominated by HOD
The information of the seminar will be given to the examination department. The examination
department may appoint an observer to the seminars from other college/ department with the approval of
the Vice Chancellor.
The marks will be forwarded to the University examination department immediately after the seminars.
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 17 of 20
Subject Code: Subject: RESEARCH PROJECT PHASE I
Name of Candidate: Roll No:
Please evaluate out of marks as indicated.
S.N
o
Details Examiner I Examiner II Examiner III Average
Marks (50) Marks (50) Marks 505) Marks
(50)
Maximum marks in each column (15 marks x5) (10 marks x5) (10 marks x5)
1 OBJECTIVE IDENTIFIED & UNDERSTOOD
2
LITERATURE REVIEW / BACKGROUND
WORK
(Coverage, Organization, Critical review)
3 DISCUSSION/CONCLUSIONS
(Clarity, Exhaustiveness)
4 SLIDES/PRESENTATION SUBMITTED
(Readable, Adequate)
5
FREQUENCY OF INTERACTION ( Timely
submission, Interest shown, Depth,
Attitude)
Total
Signature with date
Signature and date of the Director
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 18 of 20
Semester IV
RESEARCH PROJECT (PHASE –II)
(THESIS COMPILATION & VIVA-VOCE) [Amended vide approval dated 17
th Nov 2012]
Course Code: MPU451 L-0, T-0, P-48, C-18
Dissertation work
1. The student shall meet the guide frequently for the necessary guidance for the Thesis work.
2. During the semester as well as the semester break, student should read the literature germane to the
thesis topic. The progress of the Research / thesis work should continuously be informed to the guide.
3. In the end after necessary collection of data, literature survey and research work, the student must
prepare a thesis report (Final Report). The report shall be arranged and bind in the sequence consisting
of the following:-
Format of dissertation:
At the end of the IV semester the student will submit the dissertation based on the recommendation of
the student guide’s as per the format approved by the college.
The assessment will be 25% internal and 75% external
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 19 of 20
INTERNAL ASSESSMENT
Subject Code: Subject: RESEARCH PROJECT PHASE II
Name of Candidate: Roll No:
Please evaluate out of marks as indicated.
S.N
o
Details Examiner I Examiner II Examiner III Average
Marks (25) Marks (25) Marks (25) Marks
(25)
Maximum marks in each column ( 5 marks x5) (5 marks x5) (5 marks x5)
1 OBJECTIVE IDENTIFIED & UNDERSTOOD
2
LITERATURE REVIEW / BACKGROUND
WORK
(Coverage, Organization, Critical review)
3 DISCUSSION/CONCLUSIONS
(Clarity, Exhaustiveness)
4 SLIDES/PRESENTATION SUBMITTED
(Readable, Adequate)
5
FREQUENCY OF INTERACTION ( Timely
submission, Interest shown, Depth,
Attitude)
Total
Signature with date
Signature and date of the Director
M. Pharm (Pharmaceutics) Revised Syllabus Applicable w.e.f. Academic Session 2011-12 (01112012) Page 20 of 20
EXTERNAL ASSESSMENT
Subject Code: Subject: RESEARCH PROJECT PHASE II
Please evaluate out of marks as indicated.
EVALUATION BY EXTERNAL EXAMINER
Roll
No
Student Name Criteria -1 Criteria -2 Criteria -3 Criteria -4 Criteria 5 Total
Marks (15) Marks (15) Marks (15) Marks (15) Marks (15) Marks
(75)
Criteria
No
Details of the criteria for evaluation
1 OBJECTIVE IDENTIFIED & UNDERSTOOD
2 LITERATURE REVIEW / BACKGROUND WORK
(Coverage, Organization, Critical review)
3 DISCUSSION/CONCLUSIONS
(Clarity, Exhaustiveness)
4 SLIDES/PRESENTATION SUBMITTED
(Readable, Adequate)
5 FREQUENCY OF INTERACTION ( Timely submission, Interest shown, Depth, Attitude)